Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

631
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
631
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

710
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
710
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Drug Regulation01:25

Drug Regulation

3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Global Regulatory Systems01:28

Global Regulatory Systems

965
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
965
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

3.3K
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Review of Trials for Unsuccessful Pediatric Drug Development Programs Submitted to the US Food and Drug Administration 2015-2022.

Therapeutic innovation & regulatory science·2025
Same author

Lessons in automation of meat processing.

Animal frontiers : the review magazine of animal agriculture·2022
Same author

Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and Drug Administration's Evaluation.

Antiviral research·2021
Same author

The role of the pathologist in GLP studies.

Toxicologic pathology·2014

Related Experiment Video

Updated: May 6, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.4K

The study pathologist's role in GLP studies: a regulator's perspective.

Mark Seaton1

  • 11Division of Antiviral Drug Products, FDA/CDER, Silver Spring, Maryland, USA.

Toxicologic Pathology
|November 2, 2013
PubMed
Summary
This summary is machine-generated.

Early toxicology studies inform safe starting doses for human trials. Pathologists play a crucial role in identifying potential toxicities in these critical early-phase clinical studies.

Keywords:
preclinical safety-assessment/risk managementregulatory affairssafety assessment.

More Related Videos

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices
08:53

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices

Published on: October 3, 2016

16.8K
A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

10.6K

Related Experiment Videos

Last Updated: May 6, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.4K
Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices
08:53

Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 2. General Practices

Published on: October 3, 2016

16.8K
A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
13:56

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions

Published on: July 18, 2013

10.6K

Area of Science:

  • Preclinical toxicology
  • Clinical trial design
  • Regulatory science

Background:

  • Early nonclinical toxicology studies are essential for determining safe starting doses in first-in-human (FIH) clinical trials.
  • FIH trials involve healthy volunteers who face significant risks, necessitating rigorous safety protocols.
  • Good Laboratory Practice (GLP) regulations mandate standardized systems for study conduct, documentation, and material retention.

Purpose of the Study:

  • To highlight the importance of nonclinical toxicology studies in establishing safe first-in-human trial parameters.
  • To emphasize the critical role of the study pathologist in identifying toxicological findings within the GLP framework.

Main Methods:

  • Review of standard operating procedures and regulatory requirements for nonclinical toxicology studies.
  • Examination of the pathologist's responsibilities in identifying and reporting toxicological findings.
  • Analysis of the impact of standardized systems on the reliability of safety data.

Main Results:

  • Nonclinical toxicology data directly influence the setting of safe starting doses for FIH trials.
  • The study pathologist is integral to identifying target organs of toxicity and other significant findings.
  • Adherence to GLP standards ensures the integrity and reproducibility of toxicological assessments.

Conclusions:

  • Robust nonclinical toxicology evaluations are fundamental for the safety of participants in early-phase clinical trials.
  • The pathologist's expertise, operating within a standardized GLP system, is vital for safeguarding human trial subjects.
  • Strict adherence to regulatory standards ensures the reliable identification of potential drug toxicities.